MAPT and Alzheimer disease: PET has also been used in association with MRI, demonstrating the relationship between the LC deterioration, amyloid-beta deposition and tau pathology in AD patients [31], in subjects carrying the mutation for autosomal-dominant AD [32] and in asymptomatic subjects developing cognitive decline over time [33] (Table 1).